Figure 5: Tetralinoleoyl Cardiolipin With Elamipretide Treatment

Figure 5: Tetralinoleoyl Cardiolipin With Elamipretide Treatment

(A) The effect of HF on tetralinoleoyl cardiolipin (mass-to-charge ratio, 1,448) in untreated samples is expressed as a percentage of total cardiolipin. Elamipretide-treated (B) NF hearts or (C) HF hearts showed no changes in tetralinoleoyl cardiolipin. Untreated hearts in B and C are shown with clo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chatfield, Kathryn C., Sparagna, Genevieve C., Chau, Sarah, Phillips, Elisabeth K., Amrut V. Ambardekar, Aftab, Muhammad, Mitchell, Max B., Sucharov, Carmen C., Miyamoto, Shelley D., Stauffer, Brian L.
Format: Bild
Sprache:eng
Schlagworte:
Cardiology
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:(A) The effect of HF on tetralinoleoyl cardiolipin (mass-to-charge ratio, 1,448) in untreated samples is expressed as a percentage of total cardiolipin. Elamipretide-treated (B) NF hearts or (C) HF hearts showed no changes in tetralinoleoyl cardiolipin. Untreated hearts in B and C are shown with closed circles and treated hearts with open circles. NF, n = 5; HF, n = 10. Abbreviations as in Figure 1.
DOI:10.25407/jacbts.8253419